Skip to content

Database Registry of the Intermountain Heart Collaborative Study

Database Registry of the Intermountain Heart Collaborative Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00406185
Enrollment
30000
Registered
2006-12-04
Start date
1994-10-01
Completion date
2027-03-01
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Coronary Artery Disease, Electrophysiology

Keywords

Registry, cardiac catheterization laboratory, coronary heart disease, cardiovascular disease

Brief summary

The purpose of the registry is to collect and analyze clinical and laboratory data and tissue samples from patients who are diagnosed with any type of heart disease and to collect the same information and samples from healthy controls in participating Intermountain Healthcare facilities.

Detailed description

This is a registry (database) project; there are no investigational treatments, drug or procedures associated with participation in registry activities. This project is an organized data gathering and storing (database) endeavor with specific focus on the precursors, modifiers, biological, and genetic parameters of heart disease and related medical conditions. Data collection will not immediately influence the course of treatment for any patient.Sample testing and data utilization for basic science, clinical, and epidemiologic and publication projects can be initiated using the databank. The registry will enable researchers to determine best medical practices for predicting, preventing, and treating heart disease. The registry will: 1) develop standard methods to collect data and specimens which will be used for research to characterize patients diagnosed with heart disease as well as healthy controls and to assess differences in demographics and patient outcomes in both populations; 2) collect, process, and store patients' clinical data and tissue/blood samples; 3) analyze data collected; 4) use these resources to identify genes, genetic polymorphisms, genetic mutations, clinical methods and procedures, and/or biomarkers that predict, prevent, or treat heart disease and/or are associated correlate with lifestyle or disease outcomes; 5) publish and disseminate results.

Interventions

None listed

Sponsors

Intermountain Health Care, Inc.
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. The patient (male or non-pregnant female) must be \> 18 years of age. 2. The patient or legally authorized representative must sign a written informed consent, prior to the procedure, using a form that is approved by the local Institutional Review Board.

Exclusion criteria

1. Neither patient nor patient representative understands spoken English. 2. Neither patient nor the patient's personal representative is willing to give written consent for participation. 3. Healthy control patients must sign their own consent document.

Design outcomes

Primary

MeasureTime frameDescription
Outcome Risk30 yearsTo evaluate risk factors, characteristics, and treatments to cardiovascular outcomes

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJoseph B Muhlestein, MD

Intermountain Healthcare, LDS Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 15, 2026